Wigard Kloosterman

Company: Frame Cancer Therapeutics

Job title: Chief Scientific Officer

Seminars:

Trailblazing the Development of Off-the Shelf Anti-Cancer Vaccines 5:00 pm

• Frameshift neoantigens as targets of cancer immunotherapy • Shared neopeptides emerging from frameshifts • Frame neopeptide cocktails as off-the-shelf cancer vaccinesRead more

day: Day One